Gout News

In the United States, gout is more prevalent among Black adults than white adults, as well as among men compared with women, according to data published in JAMA Network Open.

ORLANDO — Understanding the nature and role of the synovium and synovial fluid is critical to managing various types of arthritis, according to a presenter at the 2022 Rheumatology Nurses Society Annual Conference.

Allena Pharmaceuticals Inc. announced its ALLN-346 Phase 2a Study 202 examining ALLN-346 treatment in patients with gout and advanced chronic kidney disease has completed enrollment for cohorts A and B.

Patients with gout are more likely to experience a cardiovascular event following a flare, according to data published in JAMA.

Both excessive and long-term alcohol consumption, as well as any spirit consumption, predict the development of ultrasound-detected tophi and sub-tophi in patients with gout, according to data published in Arthritis Care & Research.

Despite recently updated guidelines, urate-lowering therapy use, and the achievement of urate targets, remain low for patients with gout in the United Kingdom, according to data published in Lancet Europe.

The FDA has approved the supplemental biologics license application for pegloticase, expanding the drug’s label to include co-administration with methotrexate in patients with uncontrolled gout, according to a press release.

Among kidney transplant recipients with uncontrolled gout, pegloticase showed sustained decreased serum urate levels, according to findings presented at the American Transplant Congress.

Routine, proactive therapeutic drug monitoring for patients receiving biopharmaceuticals for rheumatic and musculoskeletal diseases is not recommended, according to new points-to-consider published by EULAR.

Among the many unanswered questions about calcium pyrophosphate deposition — formerly called “pseudogout” — perhaps the most important is whether it causes osteoarthritis, a speaker said at the Congress of Clinical Rheumatology East.